Literature DB >> 342150

Circulating immune complexes in six patients with trichinosis.

M Géniteau, P J Verroust, M D Smith, L Morel-Maroger, G Saimot, J P Coulaud.   

Abstract

The sera of six patients infected with Trichinella spiralis were studied for the presence of circulating immune complexes (CIC). CIC were present in all six patients studied 1 month after infection. In two patients in whom serial serum samples were available, as clinical improvement occurred there was a decrease in the level of CIC and an increase in the fluorescent antibody titres.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 342150      PMCID： PMC1541163     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  5 in total

1.  Rabbit C1q: purification, functional and structural studies.

Authors:  J E Volanakis; R M Stroud
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

2.  Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

Authors:  C Heusser; M Boesman; J H Nordin; H Isliker
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

3.  Trichinoisis and glomerulonephritis.

Authors:  M R Schoenfeld; G T Edis
Journal:  Arch Pathol       Date:  1967-12

4.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

5.  The inhibition of complement-dependent lymphocyte rosette formation by the sera of children with steroid-sensitive hephrotic syndrome and other renal diseases.

Authors:  M D Smith; T M Barratt; A R Hayward; J F Soothill
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330
  5 in total
  1 in total

1.  Circulating immune complexes in sera of patients infected with Echinococcus granulosus.

Authors:  C Pini; R Pastore; G Valesini
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.